Targeting nucleic acids into mitochondria: progress and prospects
- PMID: 22609422
- DOI: 10.1016/j.mito.2012.05.004
Targeting nucleic acids into mitochondria: progress and prospects
Abstract
Given the essential functions of these organelles in cell homeostasis, their involvement in incurable diseases and their potential in biotechnological applications, genetic transformation of mitochondria has been a long pursued goal that has only been reached in a couple of unicellular organisms. The challenge led scientists to explore a wealth of different strategies for mitochondrial delivery of DNA or RNA in living cells. These are the subject of the present review. Targeting DNA into the organelles currently shows promise but remarkably a number of alternative approaches based on RNA trafficking were also established and will bring as well major contributions.
Keywords: Mitochondria; Nanocarriers; Neurodegenerative disease; RNA trafficking; Transfection.
Copyright © 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved. All rights reserved.
Similar articles
-
Synthetic delivery systems for intravenous administration of nucleic acids.Nanomedicine (Lond). 2007 Apr;2(2):169-81. doi: 10.2217/17435889.2.2.169. Nanomedicine (Lond). 2007. PMID: 17716119 Review.
-
Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.Mitochondrion. 2007 Feb-Apr;7(1-2):63-71. doi: 10.1016/j.mito.2006.12.003. Epub 2006 Dec 13. Mitochondrion. 2007. PMID: 17296332 Review.
-
Targeting drugs to mitochondria.Eur J Pharm Biopharm. 2012 Sep;82(1):1-18. doi: 10.1016/j.ejpb.2012.05.014. Epub 2012 Jun 9. Eur J Pharm Biopharm. 2012. PMID: 22687572 Review.
-
A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.Acc Chem Res. 2012 Jul 17;45(7):1113-21. doi: 10.1021/ar200254s. Epub 2012 Feb 10. Acc Chem Res. 2012. PMID: 22324902
-
Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.J Drug Target. 2012 May;20(4):301-28. doi: 10.3109/1061186X.2012.655247. Epub 2012 Feb 6. J Drug Target. 2012. PMID: 22303844 Review.
Cited by
-
mtDNA Heteroplasmy at the Core of Aging-Associated Heart Failure. An Integrative View of OXPHOS and Mitochondrial Life Cycle in Cardiac Mitochondrial Physiology.Front Cell Dev Biol. 2021 Feb 22;9:625020. doi: 10.3389/fcell.2021.625020. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33692999 Free PMC article. Review.
-
Engineering the plastid and mitochondrial genomes of flowering plants.Nat Plants. 2022 Sep;8(9):996-1006. doi: 10.1038/s41477-022-01227-6. Epub 2022 Aug 29. Nat Plants. 2022. PMID: 36038655 Review.
-
Insights on functionalized carbon nanotubes for cancer theranostics.J Nanobiotechnology. 2021 Dec 16;19(1):423. doi: 10.1186/s12951-021-01174-y. J Nanobiotechnology. 2021. PMID: 34915901 Free PMC article. Review.
-
Formation of Nitrogenase NifDK Tetramers in the Mitochondria of Saccharomyces cerevisiae.ACS Synth Biol. 2017 Jun 16;6(6):1043-1055. doi: 10.1021/acssynbio.6b00371. Epub 2017 Mar 3. ACS Synth Biol. 2017. PMID: 28221768 Free PMC article.
-
Clinical trials in mitochondrial disorders, an update.Mol Genet Metab. 2020 Sep-Oct;131(1-2):1-13. doi: 10.1016/j.ymgme.2020.10.002. Epub 2020 Oct 6. Mol Genet Metab. 2020. PMID: 33129691 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources